High content screening: seeing is believing

F Zanella, JB Lorens, W Link - Trends in biotechnology, 2010 - cell.com
High content screening (HCS) combines the efficiency of high-throughput techniques with
the ability of cellular imaging to collect quantitative data from complex biological systems …

Genomic screening with RNAi: results and challenges

S Mohr, C Bakal, N Perrimon - Annual review of biochemistry, 2010 - annualreviews.org
RNA interference (RNAi) is an effective tool for genome-scale, high-throughput analysis of
gene function. In the past five years, a number of genome-scale RNAi high-throughput …

[HTML][HTML] A microscale human liver platform that supports the hepatic stages of Plasmodium falciparum and vivax

S March, S Ng, S Velmurugan, A Galstian, J Shan… - Cell host & …, 2013 - cell.com
The Plasmodium liver stage is an attractive target for the development of antimalarial drugs
and vaccines, as it provides an opportunity to interrupt the life cycle of the parasite at a …

The beautiful cell: high-content screening in drug discovery

M Bickle - Analytical and bioanalytical chemistry, 2010 - Springer
The term “high-content screening” has become synonymous with imaging screens using
automated microscopes and automated image analysis. The term was coined a little over 10 …

A toolbox to study liver stage malaria

M Prudêncio, MM Mota, AM Mendes - Trends in parasitology, 2011 - cell.com
The first obligatory phase of mammalian infection by Plasmodium parasites, the causative
agents of malaria, occurs in the liver of the host. This stage of Plasmodium infection bears …

[HTML][HTML] Host-directed therapy, an untapped opportunity for antimalarial intervention

L Wei, J Adderley, D Leroy, DH Drewry, DW Wilson… - Cell Reports …, 2021 - cell.com
Host-directed therapy (HDT) is gaining traction as a strategy to combat infectious diseases
caused by viruses and intracellular bacteria, but its implementation in the context of parasitic …

Drug Screen Targeted at Plasmodium Liver Stages Identifies a Potent Multistage Antimalarial Drug

FP da Cruz, C Martin, K Buchholz… - Journal of Infectious …, 2012 - academic.oup.com
Plasmodium parasites undergo a clinically silent and obligatory developmental phase in the
host's liver cells before they are able to infect erythrocytes and cause malaria symptoms. To …

[HTML][HTML] A tetracycline-repressible transactivator system to study essential genes in malaria parasites

P Pino, S Sebastian, EBA Kim, E Bush, M Brochet… - Cell host & …, 2012 - cell.com
A major obstacle in analyzing gene function in apicomplexan parasites is the absence of a
practical regulatable expression system. Here, we identified functional transcriptional …

[HTML][HTML] RNA Interference in Schistosoma mansoni Schistosomula: Selectivity, Sensitivity and Operation for Larger-Scale Screening

S Štefanić, J Dvořák, M Horn, S Braschi… - PLoS neglected …, 2010 - journals.plos.org
Background The possible emergence of resistance to the only available drug for
schistosomiasis spurs drug discovery that has been recently incentivized by the availability …

[HTML][HTML] Host cell transcriptional profiling during malaria liver stage infection reveals a coordinated and sequential set of biological events

SS Albuquerque, C Carret, AR Grosso, AS Tarun… - BMC genomics, 2009 - Springer
Background Plasmodium sporozoites migrate to the liver where they traverse several
hepatocytes before invading the one inside which they will develop and multiply into …